Antibody Engineering and Recombinant Protein Biotechnology Unit
Edit Page
Report
Scan day: 09 February 2014 UTC
10
Virus safety - good
Description: Aims to evaluate new opportunities to immunotherapeutic approaches using recombinant antibody derivatives. Includes information on the clinical use of antibodies and bispecific antibodies, as well as how to make the latter. Based at the Department of Molecular Biomedical Research, University of Ghent, Belgium.
Molecular ImmunoBiotechnology Unit VIB-RUG Department of Molecular Biomedical Research Our mission is to develop technology based on the creation and use of molecules modifying the immune system, in order to investigate new opportunities in immunotherapy.
Size: 257 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Molecular ImmunoBiotechnology Unit |
| Keywords: | |
| Description: | Antibody Engineering and Recombinant Protein Biotechnology Research Unit at VIB, Flanders |
| IP-address: | 195.130.132.86 |
WHOIS Info
| NS | |
| WHOIS | Status: NOT AVAILABLE |
| Date |